Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Waters

Showing results (461-470 of 473) with videos related to

Pageof 48
Sort By:
Nature Biotechnology|July 1, 2020
Rapid image deconvolution and multiview fusion for optical microscopyMin Guo, Yue Li, Yijun Su, et al.
Neurology|January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD studyR N Alcalay, A Siderowf, R Ottman, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Parkinsonism & Related Disorders|August 23, 2011
The relation between depression and parkin genotype: the CORE-PD studyA Srivastava, M-X Tang, H Mejia-Santana, et al.
Neurology|March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD studyR N Alcalay, E Caccappolo, H Mejia-Santana, et al.
Neurology|December 10, 2003
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD studyS Karamohamed, A L DeStefano, J B Wilk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2005
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD studySamer Karamohamed, L I Golbe, M H Mark, et al.
The Journal of Infectious Diseases|June 15, 2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity StudyJason A Regules, Susan B Cicatelli, Jason W Bennett, et al.
Microbiology Resource Announcements|October 7, 2021
Evaluation of Genome Sequences of the Bacteriophages JeTaime and Luna22Maximiliano F Flota, Caitlyn R Moss, Mitchell F Balish, et al.
The Journal of Infectious Diseases|February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
Pageof 48

Showing results (461-470 of 473) with videos related to

Sort By:
Pageof 48
Nature Biotechnology|July 1, 2020
Rapid image deconvolution and multiview fusion for optical microscopyMin Guo, Yue Li, Yijun Su, et al.
Neurology|January 6, 2011
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD studyR N Alcalay, A Siderowf, R Ottman, et al.
Scientific Reports|January 23, 2021
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasitesDorjbal Dorjsuren, Richard T Eastman, Kathryn J Wicht, et al.
Parkinsonism & Related Disorders|August 23, 2011
The relation between depression and parkin genotype: the CORE-PD studyA Srivastava, M-X Tang, H Mejia-Santana, et al.
Neurology|March 24, 2012
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD studyR N Alcalay, E Caccappolo, H Mejia-Santana, et al.
Neurology|December 10, 2003
A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD studyS Karamohamed, A L DeStefano, J B Wilk, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 21, 2005
Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD studySamer Karamohamed, L I Golbe, M H Mark, et al.
The Journal of Infectious Diseases|June 15, 2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity StudyJason A Regules, Susan B Cicatelli, Jason W Bennett, et al.
Microbiology Resource Announcements|October 7, 2021
Evaluation of Genome Sequences of the Bacteriophages JeTaime and Luna22Maximiliano F Flota, Caitlyn R Moss, Mitchell F Balish, et al.
The Journal of Infectious Diseases|February 25, 2016
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01Ruth O Payne, Kathryn H Milne, Sean C Elias, et al.
Pageof 48